Dow Up 0.51% Nasdaq Up 0.24%

InVivo Therapeutics Holdings Corp. (NVIV)

-Other OTC
1.31 Up 0.04(3.15%) Nov 21, 3:53PM EST
Prev Close:1.27
Open:1.29
Bid:N/A
Ask:N/A
1y Target Est:3.00
Beta:1.13
Next Earnings Date:N/A
Day's Range:1.29 - 1.32
52wk Range:0.47 - 2.67
Volume:225,278
Avg Vol (3m):548,415
Market Cap:122.55M
P/E (ttm):N/A
EPS (ttm):-0.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVIV

Comparison

Symbol% ChgMkt Cap
NVIVUp 3.15%122.55M
ACORDown 0.42%1.48B
ALSE 0.00%765.88K
STEMDown 1.69%79.73M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.20
Quarterly EPS Est (Dec-14) :-0.04
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Invivo Therapeutics Holdings Corp., a development stage biomaterials and biotechnology company, focuses on developing and commercializing technologies for the treatment of spinal cord injuries (SCI). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback